Literature DB >> 19032379

Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis.

Katie Doeden1, Zhihai Ma, Balasubramanian Narasimhan, Susan M Swetter, Michael Detmar, Soheil S Dadras.   

Abstract

BACKGROUND: Sentinel lymph node (SLN) metastasis is a major determinant for staging, prognostication and clinical management of patients with cutaneous melanoma. However, the role of lymphatic vs. vascular invasion (VI) for SLN spread remains unclear.
METHODS: We compared the frequency of lymphatic invasion (LI) vs. VI in melanoma sections from 94 patients with a mean three-year clinical follow up using immunostains for the lymphatic endothelial markers D2-40 (podoplanin) and LYVE-1 and the panvascular marker CD31.
RESULTS: LI occurred more frequently than VI (16 vs. 3%, respectively, p = 0.001) and correlated with higher American Joint Committee on Cancer stage at diagnosis (p = 0.0004). In a univariate analysis, LI was strongly associated with SLN metastasis (p = 0.008), independent of tumor thickness. In a multivariate analysis, LI was not a significant risk factor for SLN metastasis. The presence of intratumoral lymphatics (ITLs) was associated with distant metastasis, whereas VI was rare and did not correlate with SLN or distant metastasis. A combination of LI and ITL had higher positive and negative predictive values for the risk of developing SLN metastasis compared with routine histology and VI.
CONCLUSION: Detection of LI in the primary tumor may aid in identifying melanoma patients with the propensity to develop SLN metastasis. (c) 2008 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2008        PMID: 19032379     DOI: 10.1111/j.1600-0560.2008.01166.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  32 in total

1.  Tumor vascularization and clinicopathologic parameters as prognostic factors in merkel cell carcinoma.

Authors:  A Bob; F Nielen; J Krediet; J Schmitter; D Freundt; D Terhorst; J Röwert-Huber; J Kanitakis; E Stockfleth; Ch Ulrich; M Weichenthal; F Egberts; B Lange-Asschenfeldt
Journal:  J Cancer Res Clin Oncol       Date:  2017-06-21       Impact factor: 4.553

2.  Identification of microRNAs associated with invasive and aggressive phenotype in cutaneous melanoma by next-generation sequencing.

Authors:  Sankhiros Babapoor; Rong Wu; James Kozubek; Donna Auidi; Jane M Grant-Kels; Soheil S Dadras
Journal:  Lab Invest       Date:  2017-02-20       Impact factor: 5.662

3.  Clinical relevance of detection of lymphovascular invasion in primary melanoma using endothelial markers D2-40 and CD34.

Authors:  Amy E Rose; Paul J Christos; Dan Lackaye; Richard L Shapiro; Russell Berman; Madhu Mazumdar; Hideko Kamino; Iman Osman; Farbod Darvishian
Journal:  Am J Surg Pathol       Date:  2011-10       Impact factor: 6.394

Review 4.  Lymphangiogenesis and lymphatic vessel remodelling in cancer.

Authors:  Steven A Stacker; Steven P Williams; Tara Karnezis; Ramin Shayan; Stephen B Fox; Marc G Achen
Journal:  Nat Rev Cancer       Date:  2014-03       Impact factor: 60.716

5.  Risk Factors for Lymphatic and Hematogenous Dissemination in Patients With Stages I to II Cutaneous Melanoma.

Authors:  Laura Calomarde-Rees; Rosario García-Calatayud; Celia Requena Caballero; Esperanza Manrique-Silva; Víctor Traves; Zaida García-Casado; Virtudes Soriano; Rajiv Kumar; Eduardo Nagore
Journal:  JAMA Dermatol       Date:  2019-06-01       Impact factor: 10.282

6.  High lymphatic vessel density and lymphatic invasion underlie the adverse prognostic effect of radial growth phase regression in melanoma.

Authors:  Sook Jung Yun; Phyllis A Gimotty; Wei-Ting Hwang; Peter Dawson; Patricia Van Belle; David E Elder; Rosalie Elenitsas; Lynn Schuchter; Paul J Zhang; DuPont Guerry; Xiaowei Xu
Journal:  Am J Surg Pathol       Date:  2011-02       Impact factor: 6.394

7.  Lymphatic invasion as a prognostic biomarker in primary cutaneous melanoma.

Authors:  Xiaowei Xu; Phyllis A Gimotty; Dupont Guerry; Giorgos Karakousis; David E Elder
Journal:  Methods Mol Biol       Date:  2014

8.  Inhibition of lymphangiogenesis and angiogenesis in breast tumor xenografts and lymph nodes by a peptide derived from transmembrane protein 45A.

Authors:  Esak Lee; Jacob E Koskimaki; Niranjan B Pandey; Aleksander S Popel
Journal:  Neoplasia       Date:  2013-02       Impact factor: 5.715

9.  A comparative study of adhesion of melanoma and breast cancer cells to blood and lymphatic endothelium.

Authors:  Sabreena Safuan; Sarah J Storr; Poulam M Patel; Stewart G Martin
Journal:  Lymphat Res Biol       Date:  2012-12-05       Impact factor: 2.589

Review 10.  Lymphangiogenesis and metastasis--a closer look at the neuropilin/semaphorin3 axis.

Authors:  Matthew T Migliozzi; Patrick Mucka; Diane R Bielenberg
Journal:  Microvasc Res       Date:  2014-08-01       Impact factor: 3.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.